Press Releases in Bioscience Sector
[PRESSWIRE] ROLLE, SWITZERLAND - 02 August, 2017 -- Zaluvida Corporate AG, a Swiss-based pioneering life science company, announced today that Daniel de Carvalho joined its leadership team as Global Director of Communications, effective immediately. Zaluvida’s flagship business units, active in the fields of antimicrobial resistance, obesity and reduction of greenhouse gas emissions, are growing steadily. This success established the need for the newly created position to drive the group’s external and internal communications and match the company’s ambitious commercial strategy.
[PRESSWIRE] Copenhagen, Denmark - 18 May, 2017 -- Do you want to pitch your food or agrotech start-up to a European audience and work with leading food companies? Then stay tuned for the European Agrofood Start-up of the Year Challenge.
[PRESSWIRE] KERALA, India, November 23, 2016 -- A new, clinical study confirms that dietary supplementation of nitrate from a natural extract of Amaranthus species nicknamed "red spinach," results in a significant increase in plasma nitrite that ultimately enhances nitric oxide.
[PRESSWIRE] OXFORD, England, November 22, 2016 -- Oxford Gene Technology (OGT), The Molecular Genetics Company has announced continued strong sales of its highly integrated molecular genetics product portfolio, delivering sustainable, profitable growth.
[PRESSWIRE] BOSTON & LONDON - 28 September, 2016 -- Outcome Capital, LLC (www.outcomecapital.com), an investment banking firm that serves middle market growth companies in life sciences and technology markets, today announced the firm has expanded its operations into Europe with a UK office in London. The company has appointed Shawn Manning, D. Phil., as Managing Director of the new office.
[PRESSWIRE] CAMBRIDGE, Mass. - 19 September, 2016 -- C4 Therapeutics (C4T) today announced that it has been named by FierceBiotech as one of 2016’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry.
[PRESSWIRE] SIOUX FALLS, South Dakota (USA) - 12 August, 2016 -- SAB Biotherapeutics, Inc. (SAB), ein führendes biopharmazeutisches Entwicklungsunternehmen, hat heute bekannt gegeben, dass klinische Studien der Phase I zur humanen Antikörperbehandlung (SAB-301) für MERS-CoV begonnen haben.
[PRESSWIRE] REYKJAVIK, Iceland - 19 May, 2016 -- Alvotech, a powerful player in the field of biopharmaceuticals, today announced that it has entered into a definitive agreement to acquire Baliopharm GmbH, a German biopharmaceutical development company, previously a subsidiary of Baliopharm AG.
[PRESSWIRE] BARCELONA, Spanien - 09 May, 2016 -- Das Biotechnologieunternehmen Bioibérica und die Fundació ACE Institut Català de Neurociències Aplicades beginnen eine randomisierte, doppelblinde Studie zur Untersuchung der Wirksamkeit und Sicherheit eines neuen ernährungsphysiologischen Wirkstoffs , der den Gedächtnisverlust bei Patienten mit milder Alzheimerkrankheit verlangsamen könnte.